Without trust, the rapid adoption of AI in healthcare could stall, pointed out Joel Gordon, UW Health’s chief medical information officer. He urged healthcare leaders to focus less on flashy rollouts and more on governance, collaboration, and meaningful metrics to ensure AI delivers lasting value. The post Don’t Let the Floor Fall Out From Under…
KFF Health News senior correspondent Renuka Rayasam discussed concerns about health care costs following the expiration of enhanced Affordable Care Act tax credits on CBS News’ CBS News 24/7 on Feb. 5. Rayasam also discussed rising health insurance costs on WUGA’s The Georgia Health Report on Jan. 30. Click here to watch Rayasam on CBS…
This brief looks at newly announced changes by HHS to the pediatric vaccination schedule, which reduce the number of vaccines recommended for all children. Implications of these changes for childhood vaccination rates and trust in public health are discussed.
HumoTech has developed a robotic platform that lets patients quickly trial multiple prosthetic or exoskeleton options in a clinic, using both objective data and patient feedback to identify the best fit. The technology aims to reduce device abandonment and improve outcomes. The post How One Company Aims to Fix the Prosthetic Fitting Process appeared first…
This brief describes Trump Administration efforts to scale back or modify data collection on sexual orientation and gender identity variables in federal surveys. It specifically focuses on changes in three national surveys that are representative of these efforts: the National Health Interview Survey (NHIS), the Medicare Current Beneficiary Survey (MCBS), and the National Crime Victimization…
This brief provides five key facts on Medicaid and immigrants as context for understanding the potential impacts of policy changes under the Trump administration.
Every year more than 10,000 taxpayer-supported public housing units are lost to disrepair. But federal lawmakers routinely ignore the full amount, around $115 billion, needed to keep the units in “decent, safe and sanitary” condition. One-time funds for public housing repairs were cut from the final version of the 2022 Inflation Reduction Act to appeal…
Roche is buying 89bio to get pegozafermin, a drug currently in two Phase 3 studies for the fatty liver disease MASH. Beyond the $2.4 billion payable when the deal closes, another $1.1 billion in contingent value right payments is tied to the achievement of commercial milestones for the projected blockbuster seller. The post Roche’s Metabolic…
[Sponsored] Using RWD to understand SDOH factors faced by patients with non-small cell lung cancer paves the way for improving health equity and more effective treatments for more people. The post The Role of RWD in Revolutionizing Clinical Trial Design appeared first on MedCity News.
Among the topics INVEST will highlight are AI in life sciences, the investor perspective in healthcare and strategic priorities for hospitals. The post A Sneak Peek of INVEST 2025 Agenda appeared first on MedCity News.